Business
Regeneron Named to Dow Jones Best-in-Class World Index for Global Responsibility Leadership for Seven Consecutive Years
Regeneron also earns spot on Dow Jones Best-in-Class North America Index for six consecutive years Recognition complements the company’s recent announcement that it will provide its new gene therapy for a form of genetic hearing loss for free in the United States, reinforcing its commitment to patient access New science-led 2030 responsibility goals reflect Regeneron’s commitment to corporate responsibility, from how it innovates to how it operates, for the good of its business and humanity TARR
About this update from Regeneron Pharmaceuticals, Inc.
[{"type":"image","alt":"Regeneron Pharmaceuticals, Inc.","displaySize":"","headline":null,"caption":"Regeneron Pharmaceuticals, Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":47,"url":"https://media.zenfs.com/en/globenewswire.com/dd48a84a10e2c569a1750589118f2d19"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/YS4R8ksqsw0QmsiNDKmPPw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTY2/https://media.zenfs.com/en/globenewswire.com/dd48a84a10e2c569a1750589118f2d19","width":300,"height":47},"resize_sm":{"url":"https://s.yimg.com/ny/api/res/1.2/YS4R8ksqsw0QmsiNDKmPPw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTY2/https://media.zenfs.com/en/globenewswire.com/dd48a84a10e2c569a1750589118f2d19","width":300,"height":47}},"lazy":false},{"type":"text","content":"Regeneron also earns spot on Dow Jones Best-in-Class North America Index for six consecutive years","length":98,"tagName":"p"},{"type":"text","content":"Recognition complements the company’s recent announcement that it will provide its new gene therapy for a form of genetic hearing loss for free in the United States, reinforcing its commitment to patient access","length":215,"tagName":"p"},{"type":"text","content":"New science-led 2030 responsibility goals reflect Regeneron’s commitment to corporate responsibility, from how it innovates to how it operates, for the good of its business and humanity","length":185,"tagName":"p"},{"type":"text","content":"TARRYTOWN, N.Y., May 08, 2026 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced it has been named to the Dow Jones Best-in-Class World Index, one of the world’s most recognized benchmarks for corporate sustainability performance. Regeneron is one of only eight biotechnology companies globally included in the index. The company was also named to Dow Jones Best-in-Class North America Index, where it is one of only four U.S.-based biotechnology firms recognized. These distinctions reflect Regeneron’s long-term commitment to embed responsibility into every dimension of its business, from how it discovers groundbreaking medicines to how it operates as a company.","length":698,"tagName":"p"},{"type":"text","content":""At Regeneron, responsibility is at the heart of our science and everything we do," said Leonard S. Schleifer, M.D., Ph.D., Board co-Chair, President and Chief Executive Officer of ...